<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02075476</url>
  </required_header>
  <id_info>
    <org_study_id>FRALUX-34</org_study_id>
    <nct_id>NCT02075476</nct_id>
  </id_info>
  <brief_title>Effectiveness Between Two Surgical Techniques for Reconstruction of Humeral Proximal Extremity Fractures</brief_title>
  <official_title>Prospective, Randomized and Double Blind Study of Parallels Groups for Evaluating the Effectiveness Between Two Surgical Techniques for Reconstruction of Humeral Proximal Extremity Fractures in Three or Four Fragments</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Carlos Alvarez</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital General Universitario Gregorio Marañon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the effectiveness and safety of two surgical
      techniques for the treatments of proximal extremity humeral fractures and fractures luxation
      in three o four fragments of Neer's classification.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Proximal extremity humeral fractures present high prevalence. It's estimated about 10% of all
      fractures. Their incidence is 6,6/1000 people-year and this amount increases from 40 years
      old. The majority are successfully treated with immobilization and rehabilitation. The
      surgical treatment is recommended in case of displacement. In elderly population with
      fractures types three or four of Neer's classification there is no consensus on which
      technique is the best surgical option. Classically hemiarthroplasty has been widely performed
      as a reconstruction method but its outcomes in old patients are unclear due to the bad bone
      quality and joint features. Recently some authors recommend the reverse arthroplasty in
      patients over 70 years old . The aim of this study is to compare the results between
      Hemiarthroplasty and reverse arthroplasty in patients over 70 years old. As far as the
      investigators are concerned there's no published studies like this.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 2013</start_date>
  <completion_date type="Actual">August 6, 2016</completion_date>
  <primary_completion_date type="Actual">August 5, 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Effectiveness Will be Measured for AMERICAN SHOULDER AND ELBOW (ASES) Score</measure>
    <time_frame>36 months</time_frame>
    <description>changes en ASES (AMERICAN SHOULDER AND ELBOW) score will be measured.
The ASES questionnaire is composed of both a physician-rated component and a patient-reported component. The patient questions focus on joint pain, instability, and activities of daily living. This questionary includes a section on pain (7 items) and a section on activities of daily living (10 items). Scores range from 0 to 100 with a score of 0 indicating a worse shoulder condition and 100 indicating a better shoulder condition.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Effectiveness Will be Measured for Constant Score</measure>
    <time_frame>36 months</time_frame>
    <description>changes in Constant score will be measured.
The Constant-Murley score (CMS) is a 100-points scale composed of a number of individual parameters. These parameters define the level of pain and the ability to carry out the normal daily activities of the patient. The Constant-Murley score was introduced to determine the functionality after the treatment of a shoulder injury.
The test is divided into four subscales: pain (15 points), activities of daily living (20 points), strength (25 points) and range of motion: forward elevation, external rotation, abduction and internal rotation of the shoulder (40 points). The higher the score, the higher the quality of the function.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Effectiveness Will be Measured for DASH (Disabilities of the Arm, Shoulder and Hand) Score</measure>
    <time_frame>36 months</time_frame>
    <description>changes in DASH (Disabilities of the Arm, Shoulder and Hand) score will be measured.
The Disabilities of the Arm, Shoulder and Hand (DASH) outcome measure is a 30-item, self-report questionnaire designed to assess the patient's health status during the previous week. The items enquire about the degree of difficulty in performing different physical activities because of arm, shoulder and hand problems (21 items), the severity of each of the symptoms of pain, activity-related pain, tingling, weakness and stiffness (five items) and the impact of the problem on social functioning, work, sleep and self-image (four items). Each item has five response options. The scores are then used to calculate a scale score ranging from 0 (no disability) to 100 (most severe disability)</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>A02.835.232.087.090.400.400</condition>
  <arm_group>
    <arm_group_label>Hemiarthroplasty Global Fx(DePuy)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>in this technique the prosthesis is implanted in similar approach to shoulder anatomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>reverse arthroplasty Delta Xtent(DePuy)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In this technique the prosthesis is implanted in the inverse mode of shoulder anatomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Hemiarthroplasty</intervention_name>
    <arm_group_label>Hemiarthroplasty Global Fx(DePuy)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>reverse arthroplasty</intervention_name>
    <arm_group_label>reverse arthroplasty Delta Xtent(DePuy)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with humeral proximal extremity fracture or fracture luxation in three or
             four fragments of Neer's classification.

          -  Patient 70 years older

          -  Signed informed consent.

        Exclusion Criteria:

          -  Any condition to make worse the functional recovery or avoid the patient collaboration
             with the rehabilitation program ( cognitive disability, neurological pathology…)

               -  Glenohumeral osteoarthritis

               -  Inflammatory arthropathies

               -  Previous cuff arthropatyy

               -  High surgical or anesthesia risk

               -  Any disease or condition that the investigator finds decisive for exclusion.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>70 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carlos Alvarez, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital General Universitario Gregorio Marañon</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital General Universitario Gregorio Marañon</name>
      <address>
        <city>Madrid</city>
        <zip>28007</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>February 6, 2014</study_first_submitted>
  <study_first_submitted_qc>February 27, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 3, 2014</study_first_posted>
  <results_first_submitted>March 3, 2020</results_first_submitted>
  <results_first_submitted_qc>April 1, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">April 14, 2020</results_first_posted>
  <last_update_submitted>April 1, 2020</last_update_submitted>
  <last_update_submitted_qc>April 1, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Hospital General Universitario Gregorio Marañon</investigator_affiliation>
    <investigator_full_name>Carlos Alvarez</investigator_full_name>
    <investigator_title>Head of Department</investigator_title>
  </responsible_party>
  <keyword>Fracture-luxation</keyword>
  <keyword>humeral proximal extremity</keyword>
  <keyword>Hemiarthroplasty</keyword>
  <keyword>reverse Arthroplasty</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fractures, Bone</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Hemiarthroplasty Global Fx(DePuy)</title>
          <description>in this technique the prosthesis is implanted in similar approach to shoulder anatomy
Hemiarthroplasty</description>
        </group>
        <group group_id="P2">
          <title>Reverse Arthroplasty Delta Xtent(DePuy)</title>
          <description>In this technique the prosthesis is implanted in the inverse mode of shoulder anatomy
reverse arthroplasty</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="17"/>
                <participants group_id="P2" count="15"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="5"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>All patients 70 years of age or older with 3- or 4-part shoulder fractures were included in the study</population>
      <group_list>
        <group group_id="B1">
          <title>Hemiarthroplasty Global Fx(DePuy)</title>
          <description>in this technique the prosthesis is implanted in similar approach to shoulder anatomy
Hemiarthroplasty</description>
        </group>
        <group group_id="B2">
          <title>Reverse Arthroplasty Delta Xtent(DePuy)</title>
          <description>In this technique the prosthesis is implanted in the inverse mode of shoulder anatomy
reverse arthroplasty</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="20"/>
            <count group_id="B2" value="19"/>
            <count group_id="B3" value="39"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="20"/>
                    <count group_id="B2" value="19"/>
                    <count group_id="B3" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="76" lower_limit="71" upper_limit="85"/>
                    <measurement group_id="B2" value="77" lower_limit="71" upper_limit="85"/>
                    <measurement group_id="B3" value="76" lower_limit="71" upper_limit="85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="20"/>
                    <count group_id="B2" value="19"/>
                    <count group_id="B3" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="27"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Spain</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="20"/>
                    <count group_id="B2" value="19"/>
                    <count group_id="B3" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="19"/>
                    <measurement group_id="B3" value="39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Effectiveness Will be Measured for AMERICAN SHOULDER AND ELBOW (ASES) Score</title>
        <description>changes en ASES (AMERICAN SHOULDER AND ELBOW) score will be measured.
The ASES questionnaire is composed of both a physician-rated component and a patient-reported component. The patient questions focus on joint pain, instability, and activities of daily living. This questionary includes a section on pain (7 items) and a section on activities of daily living (10 items). Scores range from 0 to 100 with a score of 0 indicating a worse shoulder condition and 100 indicating a better shoulder condition.</description>
        <time_frame>36 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Hemiarthroplasty Global Fx(DePuy)</title>
            <description>in this technique the prosthesis is implanted in similar approach to shoulder anatomy
Hemiarthroplasty</description>
          </group>
          <group group_id="O2">
            <title>Reverse Arthroplasty Delta Xtent(DePuy)</title>
            <description>In this technique the prosthesis is implanted in the inverse mode of shoulder anatomy
reverse arthroplasty</description>
          </group>
        </group_list>
        <measure>
          <title>Effectiveness Will be Measured for AMERICAN SHOULDER AND ELBOW (ASES) Score</title>
          <description>changes en ASES (AMERICAN SHOULDER AND ELBOW) score will be measured.
The ASES questionnaire is composed of both a physician-rated component and a patient-reported component. The patient questions focus on joint pain, instability, and activities of daily living. This questionary includes a section on pain (7 items) and a section on activities of daily living (10 items). Scores range from 0 to 100 with a score of 0 indicating a worse shoulder condition and 100 indicating a better shoulder condition.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="66" lower_limit="60" upper_limit="81"/>
                    <measurement group_id="O2" value="77" lower_limit="72" upper_limit="85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Normality in sample distribution was tested using the Kolmororov-Smirnov test and graphic models. For descriptive variables we use Pearson's Chi-square, and for the study of numerical variables over time we use a mixed linear test.</non_inferiority_desc>
            <p_value>0.048</p_value>
            <method>Mixed Models Analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Effectiveness Will be Measured for Constant Score</title>
        <description>changes in Constant score will be measured.
The Constant-Murley score (CMS) is a 100-points scale composed of a number of individual parameters. These parameters define the level of pain and the ability to carry out the normal daily activities of the patient. The Constant-Murley score was introduced to determine the functionality after the treatment of a shoulder injury.
The test is divided into four subscales: pain (15 points), activities of daily living (20 points), strength (25 points) and range of motion: forward elevation, external rotation, abduction and internal rotation of the shoulder (40 points). The higher the score, the higher the quality of the function.</description>
        <time_frame>36 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Hemiarthroplasty Global Fx(DePuy)</title>
            <description>in this technique the prosthesis is implanted in similar approach to shoulder anatomy
Hemiarthroplasty</description>
          </group>
          <group group_id="O2">
            <title>Reverse Arthroplasty Delta Xtent(DePuy)</title>
            <description>In this technique the prosthesis is implanted in the inverse mode of shoulder anatomy
reverse arthroplasty</description>
          </group>
        </group_list>
        <measure>
          <title>Effectiveness Will be Measured for Constant Score</title>
          <description>changes in Constant score will be measured.
The Constant-Murley score (CMS) is a 100-points scale composed of a number of individual parameters. These parameters define the level of pain and the ability to carry out the normal daily activities of the patient. The Constant-Murley score was introduced to determine the functionality after the treatment of a shoulder injury.
The test is divided into four subscales: pain (15 points), activities of daily living (20 points), strength (25 points) and range of motion: forward elevation, external rotation, abduction and internal rotation of the shoulder (40 points). The higher the score, the higher the quality of the function.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="53" lower_limit="45" upper_limit="59"/>
                    <measurement group_id="O2" value="70" lower_limit="65" upper_limit="80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Normality in sample distribution was tested using the Kolmororov-Smirnov test and graphic models. For descriptive variables we use Pearson's Chi-square, and for the study of numerical variables over time we use a mixed linear test.</non_inferiority_desc>
            <p_value>0.001</p_value>
            <method>Mixed Models Analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Effectiveness Will be Measured for DASH (Disabilities of the Arm, Shoulder and Hand) Score</title>
        <description>changes in DASH (Disabilities of the Arm, Shoulder and Hand) score will be measured.
The Disabilities of the Arm, Shoulder and Hand (DASH) outcome measure is a 30-item, self-report questionnaire designed to assess the patient's health status during the previous week. The items enquire about the degree of difficulty in performing different physical activities because of arm, shoulder and hand problems (21 items), the severity of each of the symptoms of pain, activity-related pain, tingling, weakness and stiffness (five items) and the impact of the problem on social functioning, work, sleep and self-image (four items). Each item has five response options. The scores are then used to calculate a scale score ranging from 0 (no disability) to 100 (most severe disability)</description>
        <time_frame>36 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Hemiarthroplasty Global Fx(DePuy)</title>
            <description>in this technique the prosthesis is implanted in similar approach to shoulder anatomy
Hemiarthroplasty</description>
          </group>
          <group group_id="O2">
            <title>Reverse Arthroplasty Delta Xtent(DePuy)</title>
            <description>In this technique the prosthesis is implanted in the inverse mode of shoulder anatomy
reverse arthroplasty</description>
          </group>
        </group_list>
        <measure>
          <title>Effectiveness Will be Measured for DASH (Disabilities of the Arm, Shoulder and Hand) Score</title>
          <description>changes in DASH (Disabilities of the Arm, Shoulder and Hand) score will be measured.
The Disabilities of the Arm, Shoulder and Hand (DASH) outcome measure is a 30-item, self-report questionnaire designed to assess the patient's health status during the previous week. The items enquire about the degree of difficulty in performing different physical activities because of arm, shoulder and hand problems (21 items), the severity of each of the symptoms of pain, activity-related pain, tingling, weakness and stiffness (five items) and the impact of the problem on social functioning, work, sleep and self-image (four items). Each item has five response options. The scores are then used to calculate a scale score ranging from 0 (no disability) to 100 (most severe disability)</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26" lower_limit="13" upper_limit="33"/>
                    <measurement group_id="O2" value="13" lower_limit="10" upper_limit="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Normality in sample distribution was tested using the Kolmororov-Smirnov test and graphic models. For descriptive variables we use Pearson's Chi-square, and for the study of numerical variables over time we use a mixed linear test.</non_inferiority_desc>
            <p_value>0.011</p_value>
            <method>Mixed Models Analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>36 months</time_frame>
      <desc>Patient follow-up was done in consultations through five successive visits, at 6 weeks, at 3 months, at 6 months, a year, and the final review (minimum 40 months). These reviews were carried out by a specialist who was unaware of the prosthetic model that patients were wearing. (Masking technique).
As an adverse event we have collected the appearance of infections, instability or prosthetic loosening.
No infections, instability or prosthetic loosening were reported in any patient.</desc>
      <group_list>
        <group group_id="E1">
          <title>Hemiarthroplasty Global Fx(DePuy)</title>
          <description>in this technique the prosthesis is implanted in similar approach to shoulder anatomy
Hemiarthroplasty</description>
        </group>
        <group group_id="E2">
          <title>Reverse Arthroplasty Delta Xtent(DePuy)</title>
          <description>In this technique the prosthesis is implanted in the inverse mode of shoulder anatomy
reverse arthroplasty</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Carlos Álvarez</name_or_title>
      <organization>Hospital Gregorio Marañón</organization>
      <phone>0034915868000</phone>
      <email>calvargon@gmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

